Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026
Rhea-AI Summary
Health Catalyst (Nasdaq: HCAT) will release its fourth quarter and year-end 2025 operating results on Thursday, March 12, 2026, after market close, and will host a conference call the same day at 5:00 pm ET. The call includes dial-in numbers, conference ID “HCATQ425,” and a live audio webcast at the company investor site.
A webcast replay will be available on-demand at the same link shortly after the call and will remain available for approximately 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – HCAT
On the day this news was published, HCAT gained 3.70%, reflecting a moderate positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $4M to the company's valuation, bringing the market cap to $123M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
HCAT fell 7.43% while peers showed mixed moves. SOPH, LFMD, and CCLD were modestly down, but MNDR and SLP were up, and only MNDR appeared in momentum scans with an 11.81% decline, suggesting HCAT’s move looks more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 18 | CEO transition | Positive | +2.3% | CEO succession accelerated with Ben Albert appointed as Chief Executive Officer. |
| Dec 02 | Board change | Positive | -5.2% | Largest shareholder’s CEO joined the board, increasing governance and capital-markets focus. |
| Nov 14 | Investor conferences | Neutral | -1.1% | Management scheduled multiple late‑2025 investor conference appearances and meetings. |
| Nov 10 | Q3 2025 earnings | Positive | -5.6% | Q3 2025 results beat guidance and full‑year 2025 guidance was reaffirmed. |
| Nov 10 | Customer platform deal | Positive | -5.6% | UnityPoint Health migrated from legacy platform to next‑generation Ignite analytics platform. |
Recent history shows frequent negative price reactions to generally positive or neutral corporate updates, including earnings and customer news.
Over the last few months, Health Catalyst has focused on leadership changes, governance, investor outreach, and execution. A new CEO took over on Feb 12, 2026, with shares rising 2.31% after that announcement. Earlier, the largest shareholder’s CEO joined the board, and management attended multiple investor conferences in late 2025. Q3 2025 results beat guidance and reaffirmed full-year 2025 targets, yet the stock declined 5.61%. A major client’s migration to the Ignite platform on the same day also saw a similar selloff, highlighting a pattern of weak reactions to constructive news.
Market Pulse Summary
This announcement sets expectations for fourth quarter and year‑end 2025 results, with a release on March 12, 2026 and a conference call at 5:00 pm ET. Investors can use the webcast and 90‑day replay to evaluate any updates to growth, profitability, and guidance. Recent history, including leadership changes and prior earnings, provides important context for assessing whether upcoming disclosures represent continuity or a shift in trajectory.
AI-generated analysis. Not financial advice.
SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Conference Call Details
The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID “HCATQ425.” A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,100 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem, Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Health Catalyst Media Contact:
Kathryn Mykleseth
Director of Public Relations and Communications
media@healthcatalyst.com
Health Catalyst Investor Relations Contact:
Matt Hopper
SVP of Finance and Head of Investor Relations
ir@healthcatalyst.com
FAQ
When will Health Catalyst (HCAT) report Q4 and year-end 2025 results?
How can investors join the Health Catalyst (HCAT) March 12, 2026 conference call?
Will Health Catalyst (HCAT) provide a webcast and replay for the March 12, 2026 call?
What time is the Health Catalyst (HCAT) earnings call on March 12, 2026 and what is the conference ID?
Where can shareholders find the Health Catalyst (HCAT) Q4 2025 results and call materials?
